Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Olink Holding Ab [Publ] ADR (NQ: OLK )

26.08 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 26.08
Bid (Size) 26.02 (47)
Ask (Size) 26.03 (1)
Prev. Close 26.08
Today's Range 26.08 - 26.08
52wk Range 14.10 - 26.08
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Notice to attend the Extra General Meeting of Olink Holding AB (publ)
From Olink Proteomics AB
Via GlobeNewswire
Thermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering Period
From Thermo Fisher Scientific Inc.
Via Business Wire

Performance

YTD
+4.32%
+4.32%
1 Month
N/A
N/A
3 Month
+8.89%
+8.89%
6 Month
+5.54%
+5.54%
1 Year
+56.92%
+56.92%

More News

Read More
Olink Announces Receipt of CMA Clearance for Proposed Acquisition by Thermo Fisher
From Olink Proteomics AB
Via GlobeNewswire
Recap: Olink Holding Q4 Earnings
Via Benzinga
Olink Holding: Q3 Earnings Insights
Via Benzinga
Report from the Extra General Meeting of Olink Holding AB (publ) on 5 July 2024
From Olink Proteomics AB
Via GlobeNewswire
Olink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker Discovery
From Olink Proteomics AB
Via GlobeNewswire
Notice to attend the Extra General Meeting of Olink Holding AB (publ)
From Olink Proteomics AB
Via GlobeNewswire
Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence
From Olink Proteomics AB
Via GlobeNewswire
Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis
From Olink Proteomics AB
Via GlobeNewswire
OLK Stock Earnings: Olink Holding Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Olink reports first quarter 2024 financial results
From Olink Proteomics AB
Via GlobeNewswire
Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024
From Olink Proteomics AB
Via GlobeNewswire
Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease
From Olink Proteomics AB
Via GlobeNewswire
OLK Stock Earnings: Olink Holding Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Olink publishes 2023 annual report
From Olink Proteomics AB
Via GlobeNewswire
Olink reports fourth quarter and full year 2023 financial results
From Olink Proteomics AB
Via GlobeNewswire
Notice to attend the Annual General Meeting of Olink Holding AB (publ)
From Olink Proteomics AB
Via GlobeNewswire
Olink announces change of date for Annual General Meeting
From Olink Proteomics AB
Via GlobeNewswire
Forget Quantum-Si Stock, Olink Acquirer Thermo Fisher Is a Better Long-Term Investment
Via The Motley Fool
Olink reports third quarter 2023 financial results
From Olink Proteomics AB
Via GlobeNewswire
Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics
From Olink Proteomics AB
Via GlobeNewswire
OLINK HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olink Holding AB - OLK
From Kahn Swick & Foti, LLC
Via Business Wire
Should You Still Buy the Nasdaq's Best-Performing October Stocks?
Via The Motley Fool
Top 5 Health Care Stocks That Should Keep You Up At Night
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.